IgG4相关病中同种型特异性自身抗体谱与临床免疫学特征相关
该研究纳入61例IgG4-RD、31例SLE、11例SS患者及30例健康对照,用自制ELISA检测同种型特异性自身抗体,发现IgG4-RD存在超出IgG4的广泛同种型升高,抗体谱与免疫学指标及临床表型相关,免疫抑制治疗后多种自身抗体显著下降。
要点
- IgG4-RD存在超出IgG4的广泛同种型自身抗体升高,抗Prohibitin IgG4阳性率达100%。
- 抗Galectin-3 IgG4在胰肝胆疾病组最高(72.73%),在腹膜后纤维化/主动脉炎组最低(16.67%)。
- 37项稳健关联(FDR<0.05)主要将抗原特异性IgG3和IgG4抗体与血清免疫球蛋白、CCL18、IL-10和IL-6联系起来。
核心结论
- IgG4-RD具有复杂且同种型多样的自身抗体谱,与患者免疫实验室特征和临床表型相关。
研究设计与样本
- 研究纳入61例IgG4-RD、31例SLE、11例SS患者和30例健康对照,用自制ELISA检测同种型特异性自身抗体。
- 采用Spearman分析结合Benjamini-Hochberg FDR校正评估相关性,并通过下颌下腺活检的免疫组化和多重免疫荧光进行组织验证。
- 对12例患者治疗前后配对血清评估自身抗体同种型的纵向变化。
主要发现
- IgG4-RD显示超出IgG4的广泛同种型升高,抗Annexin A11 IgG4阳性率为80.33%,抗Galectin-3 IgG4为59.02%,抗Prohibitin IgG4为100%。
- 抗Galectin-3 IgG4在胰肝胆疾病表型中最高(72.73%),在腹膜后纤维化/主动脉炎组最低(16.67%);抗Galectin-3 IgE在头颈部局限型中更易检出(26.09%)。
- 相关性分析在IgG4-RD中识别出37项稳健关联(FDR<0.05),主要将抗原特异性IgG3和IgG4抗体与血清免疫球蛋白、CCL18、IL-10和IL-6联系起来。
- 纵向配对分析证实免疫抑制治疗后多种检测的自身抗体显著下降。
关键数值与推荐
- 抗Annexin A11 IgG4阳性率80.33%,抗Galectin-3 IgG4阳性率59.02%,抗Prohibitin IgG4阳性率100%(IgG4-RD患者)。
- 抗Galectin-3 IgG4在胰肝胆疾病组阳性率72.73%,在腹膜后纤维化/主动脉炎组16.67%;抗Galectin-3 IgE在头颈部局限型阳性率26.09%。
- 37项关联的FDR<0.05。
临床怎么用
- 同种型特异性自身抗体谱可能有助于关联IgG4-RD的免疫实验室特征与临床表型。
- 免疫抑制治疗后自身抗体同种型水平下降,提示其或可用于纵向监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: IgG4-related disease (IgG4-RD) involves elevated serum IgG4 and several autoantigens, but the role of different antibody isotypes in pathogenesis remains unclear. This study systematically characterized isotype‑specific autoantibody responses against representative autoantigens and evaluated their clinical and immunological correlations. METHODS: We enrolled 61 patients with IgG4‑RD, 31 with systemic lupus erythematosus (SLE), 11 with Sjögren's syndrome (SS), and 30 healthy controls (HC). Serum levels of isotype‑specific autoantibodies were measured using in‑house ELISA. Correlations with clinical and immunological parameters were evaluated using Spearman analysis with Benjamini‑Hochberg false discovery rate (FDR) correction. Tissue validation was performed via immunohistochemistry (IHC) and multiplex immunofluorescence (mIF) on submandibular gland biopsies. Longitudinal changes in autoantibody isotypes were assessed in paired pre‑ and post‑treatment sera from 12 patients. RESULTS: IgG4‑RD exhibited broad isotype elevations extending beyond IgG4, with positivity rates of 80.33% for anti‑Annexin A11 IgG4, 59.02% for anti‑Galectin‑3 IgG4, and 100% for anti‑Prohibitin IgG4. Phenotype‑restricted patterns were observed: anti‑Galectin‑3 IgG4 was highest in Pancreato‑hepato‑biliary disease (72.73%) but lowest in Retroperitoneal fibrosis/aortitis group (16.67%), whereas anti‑Galectin‑3 IgE was more easily detected in Head‑and‑neck‑limited phenotype (26.09%). Correlation analyses identified 37 robust associations (FDR < 0.05) in IgG4‑RD, predominantly linking antigen‑specific IgG3 and IgG4 antibodies with serum immunoglobulins, CCL18, IL‑10, and IL‑6. Longitudinal paired analysis confirmed significant decrease of multiple detected autoantibodies following immunosuppressive therapy. CONCLUSIONS: Our findings demonstrate that IgG4‑RD encompasses a complex and isotopically diverse autoantibody profile that is associated with immuno-laboratory features and clinical phenotypes of IgG4-RD patients.
引用
- Lin SY, Bai L, Liao C, et al. Isotype-specific autoantibody profiles associated with clinical immunological signatures in IgG4-RD. Rheumatology (Oxford). 2026. PMID: 42898012. doi:10.1093/rheumatology/keag585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。